logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11406705 B1

PDFFull Text
Date of Patent:
Aug. 09, 2022

Filed:

Sep. 27, 2016

Methods of using low dose volume b-cell epitope compositions for inducing an antibody immune response in human subjects

Applicant:

Immunovaccine Technologies Inc., Dartmouth, CA;

Inventors:

Marc Mansour, Halifax, CA;

Frederic Ors, Quebec, CA;

Marianne Stanford, Nova Scotia, CA;

Leeladhar Sammatur, Irvine, CA;

Rajkannan Rajagopalan, Dartmouth, CA;

Lisa Diana MacDonald, Halifax, CA;

Assignee:

IMMUNOVACCINE TECHNOLOGIES INC., Dartmouth, CA;

Attorney:

Troutman Pepper Hamilton Sanders LLP

Primary Examiner:

Agnieszka Boesen

Int. Cl.
CPC ...
C07K 14/775 (2006.01); A61K 39/39 (2006.01); A61K 39/12 (2006.01); A61P 37/04 (2006.01); A61P 31/14 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 39/12 (2013.01); A61P 31/14 (2018.01); A61P 37/04 (2018.01); C07K 14/775 (2013.01); C12N 7/00 (2013.01); A61K 2039/54 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/55572 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6018 (2013.01); A61K 2039/6031 (2013.01); C07K 2319/33 (2013.01); C12N 2760/18534 (2013.01); C12N 2760/18571 (2013.01);
Abstract

The present disclosure provides methods, uses and compositions and kits for use in inducing an antibody immune response in a human subject. The methods and uses involve administering parenterally a low dose volume of a composition comprising an antigen comprising a B-cell epitope, an amphipathic compound, and a hydrophobic carrier, wherein the low dose volume of the composition is less than 100 μl and induces an antibody immune response to the B-cell epitope in the human subject.

Find Patent Forward Citations

Mansour, Marc. (2022). Methods of using low dose volume b-cell epitope compositions for inducing an antibody immune response in human subjects (U.S. Patent No. 11406705). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11406705

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…